Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.

Status:
Completed

Trial end date:
2021-07-19

Target enrollment:

Participant gender:

The study will be conducted as a Phase 1, open-label, single-dose, randomized, 2- or 3 period, cross over design in a single cohort.

Phase 1

Pfizer